MSD R&D (China) Co., Ltd. clinical trials
A country office of Merck & Co., Inc
The registry lists 2 studies whose lead sponsor is MSD R&D (China) Co., Ltd. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 30, 2026.
- 2studies on the registry
- 2open to participants now
What it is testing
The drugs MSD R&D (China) Co., Ltd.’s studies test, most open studies first — 1 drug with a page of their own. Each count opens the studies in search.
Open now Not open: under way, finished or stopped
All 2 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
- Open now2100%
Over the years
- 121
- 22
- 23
- 24
- 25
- 026
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
- MSD R&D (China) Co., Ltd.2 studies
Something wrong with this grouping? Tell us on the Merck & Co., Inc page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Merck & Co., Inc studies →
- A Clinical Study of MK-1045 (CN201) in People With Precursor B-cell Acute Lymphoblastic Leukemia (MK-1045-002)RecruitingNCT05579132Phase 1/2
Sponsor listed in the registry: MSD R&D (China) Co., Ltd.
- A Study to Evaluate MK-1045 (CN201) in Participants With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (MK-1045-001/CN201-101)RecruitingNCT06189391Phase 1
Sponsor listed in the registry: MSD R&D (China) Co., Ltd.